Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | QNCX Quince Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $31.01 -0.5% | $16.31 +6.3% |
| StockIQ Score | 54C- Moderate Risk: High | 42D Weak Risk: Medium |
| Technical | 69B- | 36F |
| Fundamental | 53C- | 35F |
| Growth | 32F | 50C- |
| Fair Value | 38F | 38F |
| News | 86A | 50C- |
| Quality | 55C | 50C- |
| Risk | 32F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Quince Therapeutics (QNCX) outperforms Ascentage Pharma (AAPG) in technical (69 vs. 36) and investor scores (54 vs. 42), reflecting stronger market trends and investor confidence. However, AAPG shows better growth potential (50 vs. 32) and equal valuation (38 vs. 38). QNCX has a moderate rating, while AAPG is rated weak.
